Levonorgestrel-releasing intrauterine device
1 paper2 findings
- 1 lab in 1 country
- Funder: Technion-Israel Institute of Technology
- Humans1
Outcomes
2Ovarian cancer
no changein humans1
1 study
Ovarian cancer
no changein humans1
Levonorgestrel-releasing intrauterine device has no effect on ovarian cancer in humans.
HumansBRCA1 or BRCA2 pathogenic variant carriersfemales
Hormonal contraceptives and cancer risk in women with a BRCA1 or BRCA2 pathogenic variant
Breast cancer (Tokyo, Japan)18 Aug 2026
Breast cancer
no changein humans1
1 study
Breast cancer
no changein humans1
Levonorgestrel-releasing intrauterine device has no effect on breast cancer in humans.
HumansBRCA1 or BRCA2 pathogenic variant carriersfemales
Hormonal contraceptives and cancer risk in women with a BRCA1 or BRCA2 pathogenic variant
Breast cancer (Tokyo, Japan)18 Aug 2026
Latest
1 in 12 monthsBreast Cancer
Hormonal contraceptives and cancer risk in women with a BRCA1 or BRCA2 pathogenic variant
Cohort study of 1,677 peoplePopulations